Myocardial infarction. Initial results from the EPHESUS trial

Affiliations

Comment

Norman E Lepor. Rev Cardiovasc Med. 2005 Fall.

. 2005 Fall;6(4):227-8.

¹ David Geffen School of Medicine at UCLA, Cedars-Sinai Medical Center, Los Angeles, California, USA.

No abstract available

Comment on

Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure.
Pitt B, White H, Nicolau J, Martinez F, Gheorghiade M, Aschermann M, van Veldhuisen DJ, Zannad F, Krum H, Mukherjee R, Vincent J; EPHESUS Investigators. Pitt B, et al. J Am Coll Cardiol. 2005 Aug 2;46(3):425-31. doi: 10.1016/j.jacc.2005.04.038. J Am Coll Cardiol. 2005. PMID: 16053953 Clinical Trial.